Product Information
ARMOUR THYROID 300 MG TABLET is a brand product labeled by Allergan, Inc., priced at $2.2162 per EA under NDC 00456046401. Its NADAC has been published 430 times since Jun 18, 2014.
Strength
300 mg/1
Manufacturer
Allergan, Inc.NDC
00456046401
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SUS SCROFA THYROIDApproval Type
Unapproved
On Market Since
4/1/1996
Price Statistics
The NADAC for ARMOUR THYROID 300 MG TABLET has been published 430 times since Jun 18, 2014, and over the history we have for it it has risen 132.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2162 per EA |
|---|---|
| All-time high | $2.2162 (Jun 24, 2026) |
| All-time low | $0.9531 (Jun 18, 2014) |
| 52-week high | $2.2162 |
| 52-week low | $2.1054 |
| Median price | $1.8129 |
| Average price | $1.7220 |
| Largest weekly change | +50.0% (Jul 8, 2015) |
| Weeks tracked | 430 |
| Tracking since | Jun 18, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the THYROID, PORCINE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ARMOUR THYROID 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARMOUR THYROID 300 MG TABLET, manufactured by Allergan, Inc., is $2.2162 per EA (NDC 00456046401), effective Jun 24, 2026.
How has the price of ARMOUR THYROID 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARMOUR THYROID 300 MG TABLET has risen 132.5%. It has been tracked across 430 weekly CMS publications since Jun 18, 2014.
What are the highest and lowest recorded NADAC prices for ARMOUR THYROID 300 MG TABLET?
Since Jun 18, 2014, the NADAC for ARMOUR THYROID 300 MG TABLET has ranged from a low of $0.9531 (Jun 18, 2014) to a high of $2.2162 (Jun 24, 2026), with a median of $1.8129 per EA.
Are there cheaper alternatives to ARMOUR THYROID 300 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ARMOUR THYROID 300 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ARMOUR THYROID 300 MG TABLET?
ARMOUR THYROID 300 MG TABLET (NDC 00456046401) is labeled by Allergan, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification